Phase II randomized trial of docetaxel plus cetuximab or bortezomib in patients with advanced NSCLC and performance status (PS) 2: CALGB 30402
- Citation:
- J Clin Oncol vol 25 (18s) abstr 7595
- Year:
- 2007
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 227
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- R. C. Lilenbaum X. Wang L. Gu J. Kirshner E. E. Vokes
- Networks:
- Study
- CALGB-30402
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: